Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 4
2006 6
2007 1
2008 4
2009 7
2010 7
2011 9
2012 13
2013 9
2014 8
2015 7
2016 9
2017 9
2018 15
2019 11
2020 18
2021 26
2022 26
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

175 results
Results by year
Filters applied: . Clear all
Page 1
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
Polaris Observatory HCV Collaborators. Polaris Observatory HCV Collaborators. Lancet Gastroenterol Hepatol. 2022 May;7(5):396-415. doi: 10.1016/S2468-1253(21)00472-6. Epub 2022 Feb 16. Lancet Gastroenterol Hepatol. 2022. PMID: 35180382 Review.
BACKGROUND: Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HC …
BACKGROUND: Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 20 …
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.
Polaris Observatory HCV Collaborators. Polaris Observatory HCV Collaborators. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16. Lancet Gastroenterol Hepatol. 2017. PMID: 28404132 Review.
BACKGROUND: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direct acting antiviral therapies. ...METHODS: We developed country-level dise …
BACKGROUND: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection …
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, MacDonald SE, Janjua NZ, Tadrous M, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Chung H, et al. Among authors: janjua nz. BMJ. 2021 Aug 20;374:n1943. doi: 10.1136/bmj.n1943. BMJ. 2021. PMID: 34417165 Free PMC article.
HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men.
Adu PA, Rossi C, Binka M, Wong S, Wilton J, Wong J, Butt ZA, Bartlett S, Jeong D, Pearce M, Darvishian M, Yu A, Alvarez M, Velásquez García HA, Krajden M, Janjua NZ. Adu PA, et al. Among authors: janjua nz. Liver Int. 2021 Mar;41(3):482-493. doi: 10.1111/liv.14762. Epub 2020 Dec 22. Liver Int. 2021. PMID: 33305525
BACKGROUND & AIMS: Hepatitis C virus (HCV) reinfection among high-risk groups threatens HCV elimination goals. ...METHODS: We used data from the BC Hepatitis Testers Cohort, which includes nearly 1.7 million individuals tested for HCV or HIV in BC. MSM wh …
BACKGROUND & AIMS: Hepatitis C virus (HCV) reinfection among high-risk groups threatens HCV elimination goals. ...METHODS: …
Contextualizing Canada's hepatitis C virus epidemic.
Krajden M, Cook D, Janjua NZ. Krajden M, et al. Among authors: janjua nz. Can Liver J. 2018 Dec 25;1(4):218-230. doi: 10.3138/canlivj.2018-0011. eCollection 2018 Fall. Can Liver J. 2018. PMID: 35992621 Free PMC article. Review.
In 2016, Canada signed on to the World Health Organization (WHO) 2030 hepatitis C virus (HCV) disease elimination targets. Most of Canada's HCV disease burden is among five disproportionately affected population groups: 1) Baby boomers, who are at increased risk of …
In 2016, Canada signed on to the World Health Organization (WHO) 2030 hepatitis C virus (HCV) disease elimination targets. Most of Ca …
Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in Canada.
Darvishian M, Butt ZA, Wong S, Yoshida EM, Khinda J, Otterstatter M, Yu A, Binka M, Rossi C, McKee G, Pearce M, Alvarez M, Wong J, Cook D, Grennan T, Buxton J, Tyndall M, Woods R, Krajden M, Bhatti P, Janjua NZ. Darvishian M, et al. Among authors: janjua nz. Ther Adv Med Oncol. 2021 Feb 11;13:1758835921992987. doi: 10.1177/1758835921992987. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33633801 Free PMC article.
Compared to uninfected individuals, the risk of colorectal cancer was significantly elevated among those with HCV (Hazard ration [HR] 2.99; 95% confidence interval [CI] 2.55-3.51), HBV (HR 2.47; 95% CI 1.85-3.28), and HIV mono-infection (HR 2.30; 95% CI 1.47-3.59), and …
Compared to uninfected individuals, the risk of colorectal cancer was significantly elevated among those with HCV (Hazard ration [HR] …
Addressing hepatitis C in the foreign-born population: A key to hepatitis C virus elimination in Canada.
Greenaway C, Makarenko I, Tanveer F, Janjua NZ. Greenaway C, et al. Among authors: janjua nz. Can Liver J. 2018 Jul 17;1(2):34-50. doi: 10.3138/canlivj.1.2.004. eCollection 2018 Spring. Can Liver J. 2018. PMID: 35990716 Free PMC article. Review.
Hepatitis C virus (HCV) is the leading cause of death from infectious disease in Canada. Immigrants are an important group who are at increased risk for HCV; they account for a disproportionate number of all HCV cases in Canada (~30%) and have approximately a …
Hepatitis C virus (HCV) is the leading cause of death from infectious disease in Canada. Immigrants are an important group who are at …
The case for simplifying and using absolute targets for viral hepatitis elimination goals.
Polaris Observatory Collaborators. Polaris Observatory Collaborators. J Viral Hepat. 2021 Jan;28(1):12-19. doi: 10.1111/jvh.13412. Epub 2020 Nov 4. J Viral Hepat. 2021. PMID: 32979881
This was followed by the World Health Organization's (WHO) global targets for the care and management of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. These announcements and targets were important in raising awareness and calling for action; however, tra …
This was followed by the World Health Organization's (WHO) global targets for the care and management of hepatitis B virus (HBV) and hepatit …
The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
Bartlett SR, Wong S, Yu A, Pearce M, MacIsaac J, Nouch S, Adu P, Wilton J, Samji H, Clementi E, Velasquez H, Jeong D, Binka M, Alvarez M, Wong J, Buxton J, Krajden M, Janjua NZ. Bartlett SR, et al. Among authors: janjua nz. Clin Infect Dis. 2022 Mar 1;74(4):575-583. doi: 10.1093/cid/ciab546. Clin Infect Dis. 2022. PMID: 34125883 Free PMC article.
RESULTS: In total, 13 803 PWUD with chronic HCV were included in this study. Among those currently on OAT at the end of the study period, 47% (2704/5770) had started HCV treatment, whereas 22% (1778/8033) of those not currently on OAT had started HCV treatmen …
RESULTS: In total, 13 803 PWUD with chronic HCV were included in this study. Among those currently on OAT at the end of the study per …
175 results